LIVN
Price
$47.60
Change
+$0.11 (+0.23%)
Updated
Dec 20, 04:59 PM (EDT)
59 days until earnings call
SRDX
Price
$39.73
Change
-$0.18 (-0.45%)
Updated
Dec 20, 04:59 PM (EDT)
39 days until earnings call
Ad is loading...

LIVN vs SRDX

Header iconLIVN vs SRDX Comparison
Open Charts LIVN vs SRDXBanner chart's image
LivaNova
Price$47.60
Change+$0.11 (+0.23%)
Volume$10.15K
CapitalizationN/A
Surmodics
Price$39.73
Change-$0.18 (-0.45%)
Volume$4.09K
CapitalizationN/A
LIVN vs SRDX Comparison Chart
Loading...
LIVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LIVN vs. SRDX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIVN is a Hold and SRDX is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (LIVN: $47.59 vs. SRDX: $39.75)
Brand notoriety: LIVN and SRDX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: LIVN: 258% vs. SRDX: 152%
Market capitalization -- LIVN: $3.02B vs. SRDX: $397.04M
LIVN [@Medical Specialties] is valued at $3.02B. SRDX’s [@Medical Specialties] market capitalization is $397.04M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LIVN’s FA Score shows that 0 FA rating(s) are green whileSRDX’s FA Score has 0 green FA rating(s).

  • LIVN’s FA Score: 0 green, 5 red.
  • SRDX’s FA Score: 0 green, 5 red.
According to our system of comparison, SRDX is a better buy in the long-term than LIVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LIVN’s TA Score shows that 4 TA indicator(s) are bullish while SRDX’s TA Score has 4 bullish TA indicator(s).

  • LIVN’s TA Score: 4 bullish, 6 bearish.
  • SRDX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both LIVN and SRDX are a bad buy in the short-term.

Price Growth

LIVN (@Medical Specialties) experienced а -7.59% price change this week, while SRDX (@Medical Specialties) price change was -0.70% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Reported Earning Dates

LIVN is expected to report earnings on Feb 19, 2025.

SRDX is expected to report earnings on Jan 30, 2025.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LIVN($3.02B) has a higher market cap than SRDX($397M). LIVN has higher P/E ratio than SRDX: LIVN (172.28) vs SRDX (71.51). SRDX YTD gains are higher at: 9.354 vs. LIVN (-8.021). LIVN has higher annual earnings (EBITDA): 38.5M vs. SRDX (22.1M). LIVN has more cash in the bank: 267M vs. SRDX (35.2M). SRDX has less debt than LIVN: SRDX (33.9M) vs LIVN (640M). LIVN has higher revenues than SRDX: LIVN (1.15B) vs SRDX (138M).
LIVNSRDXLIVN / SRDX
Capitalization3.02B397M760%
EBITDA38.5M22.1M174%
Gain YTD-8.0219.354-86%
P/E Ratio172.2871.51241%
Revenue1.15B138M836%
Total Cash267M35.2M759%
Total Debt640M33.9M1,888%
FUNDAMENTALS RATINGS
LIVN vs SRDX: Fundamental Ratings
LIVN
SRDX
OUTLOOK RATING
1..100
6888
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8789
PRICE GROWTH RATING
1..100
7453
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
1n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LIVN's Valuation (82) in the Medical Specialties industry is in the same range as SRDX (92). This means that LIVN’s stock grew similarly to SRDX’s over the last 12 months.

LIVN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as SRDX (100). This means that LIVN’s stock grew similarly to SRDX’s over the last 12 months.

LIVN's SMR Rating (87) in the Medical Specialties industry is in the same range as SRDX (89). This means that LIVN’s stock grew similarly to SRDX’s over the last 12 months.

SRDX's Price Growth Rating (53) in the Medical Specialties industry is in the same range as LIVN (74). This means that SRDX’s stock grew similarly to LIVN’s over the last 12 months.

SRDX's P/E Growth Rating (94) in the Medical Specialties industry is in the same range as LIVN (100). This means that SRDX’s stock grew similarly to LIVN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LIVNSRDX
RSI
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
58%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
68%
Momentum
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
68%
MACD
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
71%
Advances
ODDS (%)
Bullish Trend 11 days ago
73%
Bullish Trend 14 days ago
71%
Declines
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 5 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 4 days ago
73%
Aroon
ODDS (%)
Bearish Trend 3 days ago
65%
Bullish Trend 3 days ago
69%
View a ticker or compare two or three
Ad is loading...
LIVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYFCX69.311.05
+1.54%
Rydex Financial Services C
MRGJX51.700.59
+1.15%
MFS Core Equity R4
WFGGX28.210.26
+0.93%
First Trust WCM Focused Global Gr Inv
VSFCX21.530.18
+0.84%
Federated Hermes Clover Small Value C
PCHSX33.60-0.12
-0.36%
Putnam Global Health Care C

LIVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIVN has been loosely correlated with AORT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if LIVN jumps, then AORT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIVN
1D Price
Change %
LIVN100%
+0.21%
AORT - LIVN
40%
Loosely correlated
+1.82%
SRDX - LIVN
35%
Loosely correlated
-0.40%
UFPT - LIVN
35%
Loosely correlated
+2.77%
ALGN - LIVN
34%
Loosely correlated
-1.18%
TMDX - LIVN
33%
Loosely correlated
+1.93%
More

SRDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRDX has been loosely correlated with LIVN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if SRDX jumps, then LIVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRDX
1D Price
Change %
SRDX100%
-0.40%
LIVN - SRDX
37%
Loosely correlated
+0.21%
RMD - SRDX
32%
Poorly correlated
+2.46%
TMDX - SRDX
29%
Poorly correlated
+1.93%
NARI - SRDX
28%
Poorly correlated
+1.91%
MBOT - SRDX
26%
Poorly correlated
+0.10%
More